T-high asthma phenotypes across life span
Nicole Maison,Jimmy Omony,Sabina Illi,Dominik Thiele,Chrysanthi Skevaki,Anna-Maria Dittrich,Thomas Bahmer,Klaus Friedrich Rabe,Markus Weckmann,Christine Happle,Bianca Schaub,Meike Meyer,Svenja Foth,Ernst Rietschel,Harald Renz,Gesine Hansen,Matthias Volkmar Kopp,Erika von Mutius,Ruth Grychtol,Oliver Fuchs,Barbara Roesler,Nils Welchering,Naschla Kohistani-Greif,Johanna Kurz,Katja Landgraf-Rauf,Kristina Laubhahn,Claudia Liebl,Markus Ege,Alexander Hose,Esther Zeitlmann,Mira Berbig,Carola Marzi,Christina Schauberger,Ulrich Zissler,Carsten Schmidt-Weber,Isabell Ricklefs,Gesa Diekmann,Lena Liboschik,Gesche Voigt,Laila Sultansei,Gyde Nissen,Inke R König,Anne-Marie Kirsten,Frauke Pedersen,Henrik Watz,Benjamin Waschki,Christian Herzmann,Mustafa Abdo,Heike Biller,Karoline I Gaede,Xenia Bovermann,Alena Steinmetz,Berrit Liselotte Husstedt,Catharina Nitsche,Vera Veith,Marlen Szewczyk,Folke Brinkmann,Aydin Malik,Nicolaus Schwerk,Christian Dopfer,Mareike Price,Adan Chari Jirmo,Anika Habener,David S DeLuca,Svenja Gaedcke,Bin Liu,Mifflin-Rae Calveron,Stefanie Weber,Tom Schildberg,Silke van Koningsbruggen-Rietschel,Miguel Alcazar,Meike Meier,
DOI: https://doi.org/10.1183/13993003.02288-2021
IF: 24.3
2022-02-24
European Respiratory Journal
Abstract:Rationale In adults, personalised asthma treatment targets patients with T2-high and eosinophilic asthma phenotypes. It is unclear whether such classification is achievable in children. Objectives To define T2-high asthma with easily accessible biomarkers and compare resulting phenotypes across all ages. Methods In the multicenter clinical ALL Age Asthma Cohort (ALLIANCE), 1125 participants (n=776 asthmatics, n=349 controls) were recruited and followed for 2 years (1 year in adults). Extensive clinical characterisation (questionnaires, blood differential count, allergy testing, lung function and sputum induction (in adults) was performed at baseline and follow-ups. Interleukin (IL)-4, IL-5 and IL-13 were measured after stimulation of whole blood with LPS or anti-CD3/CD28. Measurements and Main Results Based on blood eosinophil counts and allergen-specific serum IgE antibodies (sIgE), patients were categorised into four mutually exclusive phenotypes: “Atopy-only”, “Eosinophils-only”, “T2-high” (eosinophilia+atopy) and “T2-low” (neither eosinophilia nor atopy). The T2-high phenotype was found across all ages, even in very young children in whom it persisted to a large degree even after 2 years of follow-up. T2-high asthma in adults was associated with childhood onset suggesting early origins of this asthma phenotype. In both children and adults, the T2-high phenotype was characterised by excessive production of specific IgE to allergens (p<0.0001) and, from school age onwards, by increased production of IL-5 after anti-CD3/CD28 stimulation of whole blood. Conclusions Using easily accessible biomarkers, patients with T2-high asthma can be identified across all ages delineating a distinct phenotype. These patients may benefit from therapy with biologicals even at younger age.
respiratory system